Biotage, a Swedish-based biotechnology company, has acquired US-based company PhyNexus for USD 21.5m. PhyNexus has an innovative technology platform with patented pipette-based consumables. The acquisition will strengthen Biotage’s position within the biomolecules industry. PhyNexus reported a turnover of USD 3.1m and EBIT of USD -0.1 in 2017, corresponding to an EV/sales multiple of 6.9x.
